Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation

Takayoshi TachibanaDepartment of Hematology and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan; ;Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; Correspondence[email protected]

Kenji MatsumotoYokohama City University Medical Center, Yokohama, Japan;

Masatsugu TanakaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;

Maki HagiharaYokohama City University Medical Center, Yokohama, Japan;

Kenji MotohashiYokohama City University Medical Center, Yokohama, Japan;

Wataru YamamotoYokohama City University Medical Center, Yokohama, Japan;

Eriko OgusaDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;

Satoshi KoyamaDepartment of Hematology and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan;

Ayumi NumataYokohama City University Medical Center, Yokohama, Japan;

Naoto TomitaDepartment of Hematology and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan;

Jun TaguchiDepartment of Hematology, Shizuoka Red Cross Hospital, Shizuoka, Japan

Shin FujisawaYokohama City University Medical Center, Yokohama, Japan;

Heiwa KanamoriDepartment of Hematology, Kanagawa Cancer Center, Yokohama, Japan;

Hideaki NakajimaDepartment of Hematology and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan;

show all

Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date